Viracta Therapeutics, Inc. (VIRX) Financials
VIRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 56.7 million | 38.4 million |
2023-09-30 | 66.4 million | 36.4 million |
2023-06-30 | 76.9 million | 36.1 million |
2023-03-31 | 85.8 million | 34.7 million |
VIRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -10.0 million | 1.8 million |
2023-09-30 | -10.5 million | 1.8 million |
2023-06-30 | -8.2 million | 2.0 million |
2023-03-31 | -11.3 million | 2.1 million |
VIRX Net Income
No data available :(
VIRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 53.7 million | - | 282000 |
2023-09-30 | 63.0 million | - | 381000 |
2023-06-30 | 72.9 million | - | 475000 |
2023-03-31 | 80.3 million | 22.8 million | 563000 |
VIRX Shares Outstanding
VIRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 9.4 million | 4.2 million | 123001 |
2023-09-30 | 51000 | 8.2 million | 4.3 million | - |
2023-06-30 | 189000 | 8.2 million | 4.3 million | - |
2023-03-31 | 189000 | 7.6 million | 4.6 million | - |
VIRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 123000 |
2023-09-30 | - | 128000 |
2023-06-30 | - | 119000 |
2023-03-31 | - | 122000 |
VIRX
Price: $0.82
52 week price:
Earnings Per Share: -1.32 USD
P/E Ratio: -0.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 46946
Market Capitalization: 30.6 million